|Articles|November 1, 2003
Slow, Steady Tx Release
Author(s)Louise Gagnon
San Diego - The most current data from an open label trial show that hydroquinone 4 percent with retinol is an effective and safe option to treat melasma and post-inflammatory hyperpigmentation, according to Pearl Grimes, M.D., the study's principal investigator.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Novel Botanical Moisturizer Demonstrates Superior Efficacy Over Metronidazole in Phase 2 Rosacea Trial
2
The Emerging Role of Oral Peptide Therapeutics in Dermatology
3
Social Media Mythbusters: Dietary Skin Supplements
4
New Immune-Mediated Therapies in AD, Alopecia Areata, and HS Presented at SDNP
5










